Cencora (COR) Interest & Investment Income (2011 - 2026)
Cencora (COR) reported Interest & Investment Income of -$140.5 million for Q1 2026, down 35.07% on a YoY basis from -$216.3 million in Q1 2025, and down 93.98% quarter-over-quarter from -$72.4 million in Q4 2025.
Cencora (COR) Interest & Investment Income (2011 - 2026) Analysis & Trends
Cencora has reported Interest & Investment Income for 16 years, with the latest figure at -$140.5 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 35.07% year-over-year to -$140.5 million; the trailing twelve-month figure through Mar 2026 stood at -$372.5 million (down 102.2% YoY), and the FY2025 full-year result was -$291.5 million, down 85.71% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$140.5 million, down from -$72.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was -$21.0 million in Q3 2024, with the low at -$140.5 million in Q1 2026.
- Historically, Interest & Investment Income has averaged -$61.6 million across 5 years, with a median of -$57.9 million in 2023.
- Annual changes were most pronounced in 2024 — Interest & Investment Income jumped 65.59% — and 2025, when it tumbled 271.18%.
- Cencora's Interest & Investment Income stood at -$46.0 million in 2022, then gained by 11.85% to -$40.6 million in 2023, then surged by 31.14% to -$27.9 million in 2024, then sank by 159.22% to -$72.4 million in 2025, then slumped by 93.98% to -$140.5 million in 2026.
- The last three Interest & Investment Income figures came in at -$140.5 million (Q1 2026), -$72.4 million (Q4 2025), and -$77.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | - |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -140.46 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 7.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.71 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 46,673.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140.46 Mn |
| Dec 31, 2025 | -72.41 Mn |
| Sep 30, 2025 | -77.83 Mn |
| Jun 30, 2025 | -81.79 Mn |
| Mar 31, 2025 | -103.99 Mn |
| Dec 31, 2024 | -27.93 Mn |
| Sep 30, 2024 | -20.97 Mn |
| Jun 30, 2024 | -31.33 Mn |
| Mar 31, 2024 | -64.13 Mn |
| Dec 31, 2023 | -40.56 Mn |
| Sep 30, 2023 | -60.94 Mn |
| Jun 30, 2023 | -57.86 Mn |
| Mar 31, 2023 | -64.11 Mn |
| Dec 31, 2022 | -46.02 Mn |
| Sep 30, 2022 | -51.52 Mn |
| Jun 30, 2022 | -52.86 Mn |
| Mar 31, 2022 | -52.92 Mn |
| Dec 31, 2021 | -53.37 Mn |
| Sep 30, 2021 | -54.60 Mn |
| Jun 30, 2021 | -51.34 Mn |